Necitumumab
Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc[1].
Product Specifications
CAS Number
906805-06-9
Product Name Alternative
11F8; IMC-11F8; LY3012211
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/necitumumab.html
Purity
99.9
Solubility
10 mM in DMSO|H2O
Smiles
[Necitumumab]
Molecular Weight
(144.78 kDa)
References & Citations
[1]Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76 (2) :283-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030345 100 µg
Recombinant SARS-CoV-2 N Protein (D3L, S235F) (His Tag)
Sign In for Pricing
View Details 
